查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1542564

全球生物製药合约製造市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Biopharmaceuticals Contract Manufacturing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 172 Pages | 商品交期: 最快1-2个工作天内

价格

全球生物製药合约製造市场需求预计将从 2023 年的 197.4 亿美元达到 2032 年近 339.2 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 6.2%。

生物製药合约製造涉及将生物製药产品的生产外包给专业合约製造商。这些产品包括单株抗体、疫苗和重组蛋白等生物製品，需要复杂的製造流程和严格的品质控制。合约製造组织 (CMO) 提供服务，包括细胞株开发、製程开发和大规模生产。这种模式允许生物製药公司利用 CMO 的专业知识和能力，减少对内部生产设施和相关资本支出的需求。公司可以透过外包生产专注于研发，同时受益于 CMO 的先进技术和监管合规专业知识。

市场动态

由于对生物製剂和先进疗法的需求不断增长，生物製药合约製造市场正在经历强劲增长。生物製药公司将製造业务外包给专业合约製造商，以扩大生产能力并满足市场对单株抗体和基因疗法等复杂生物药物不断增长的需求。生物製药生产的高成本和复杂性推动了对合约製造服务的需求。合约製造商提供处理复杂生产流程和维持严格品质标准的专业知识，这对个别公司来说内部管理的成本过高。生物製药公司可以减少资本投资和营运成本，同时透过外包获得最先进的製造技术。

生物製造的技术进步正在市场中创造新的机会。一次性技术和连续製造流程等创新提高了生产效率和灵活性。这些进步可以缩短週转时间并降低污染风险，使合约製造成为生物製药公司有吸引力的选择。个人化医疗的新兴趋势也促进了生物製药合约製造市场的成长。小批量、高品质生产个人化治疗药物的需求非常适合合约製造商的能力。此外，生物技术行业的扩张和生物製药研发投资的增加正在推动对合约製造服务的需求。然而，监管的复杂性和智慧财产权盗窃的风险可能会阻碍生物製药合约製造市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球生物製药合约製造市场的每个细分市场进行了包容性评估。生物製药合约製造业的成长和趋势为本研究提供了整体方法。

市场区隔

生物製药合约製造市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按来源

  • 哺乳动物
  • 非哺乳动物

按服务

  • 製程开发（下游、上游）
  • 填充和完成操作
  • 分析和品质控制研究
  • 包装

按产品分类

  • 生物製剂（单株抗体 (MAB)、重组蛋白、疫苗、反义、RNAi 和分子疗法等）
  • 生物相似药
  • 区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲生物製药合约製造市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。生物製药合约製造市场的主要参与者包括 Boehringer Ingelheim GmbH、Lonza、Inno Biologics Sdn Bhd、Rentschler Biotechnologie GmbH、JRS Pharma、AGC Biologics、ProBioGen、Fujifilm Diosynth Biotechnologies USA, Inc.、Toyobo Co., Ltd. 、Thermo Fisher Scientific, Inc.、Binex Co., Ltd.、WuXi Biologics、AbbVie, Inc.。概览、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：生物製药合约製造 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按来源
    • 按服务
    • 按产品分类
    • ：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：COVID-19 爆发的影响分析

  • Covid-19 爆发的影响分析
    • 对生产的直接影响
    • 供应炼和市场颠覆
    • 对公司和金融市场的财务影响
  • 按生产、进口、出口和需求分類的 COVID-19 影响分析
  • 市场：COVID-19 之前/之后
  • 冠状病毒 (COVID-19) 疫情的预期影响
  • COVID-19：微观和宏观因素分析

第 6 章：全球生物製药合约製造市场分析：依来源分类

  • 按来源概述
  • 历史和预测数据
  • 按来源分析
  • 哺乳动物市场：按地区
  • 非哺乳类市场：按地区

第 7 章：全球生物製药合约製造市场分析：按服务分类

  • 按服务概览
  • 历史和预测数据
  • 按服务分析
  • 製程开发市场：按地区
  • 填充和完成操作市场：按地区
  • 分析和品质控制研究市场：按地区
  • 包装市场：按地区

第 8 章：全球生物製药合约製造市场分析：副产品

  • 按产品概述
  • 历史和预测数据
  • 按产品分析
  • 生物製品市场：按地区
  • 生物相似药市场：按地区

第 9 章：全球生物製药合约製造市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美洲
    • 概览、历史和预测数据
    • 北美按细分市场
    • 北美洲：依国家分类
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 概览、历史和预测数据
    • 欧洲按细分市场
    • 欧洲 : 按国家/地区
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 欧洲其他地区
  • 亚太地区
    • 概览、历史和预测数据
    • 亚太地区（按细分市场）
    • 亚太地区：依国家分类
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 亚太其他地区
  • 拉丁美洲
    • 概览、历史和预测数据
    • 拉丁美洲按细分市场
    • 拉丁美洲 : 依国家分类
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概览、历史和预测数据
    • 中东和非洲细分市场
    • 中东和非洲：按国家/地区
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 南非
    • 中东和非洲其他地区

第 10 章：生物製药合约製造公司的竞争格局

  • 生物製药合约製造市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 公司股份分析
  • 市场集中度
  • Boehringer Ingelheim GmbH
    • 公司概况
    • 产品
    • 最新动态
  • Lonza
    • 公司概况
    • 产品
    • 最新动态
  • Inno Biologics Sdn Bhd
    • 公司概况
    • 产品
    • 最新动态
  • Rentschler Biotechnologie GmbH
    • 公司概况
    • 产品
    • 最新动态
  • JRS Pharma
    • 公司概况
    • 产品
    • 最新动态
  • AGC Biologics
    • 公司概况
    • 产品
    • 最新动态
  • ProBioGen
    • 公司概况
    • 产品
    • 最新动态
  • Fujifilm Diosynth Biotechnologies USA, Inc.
    • 公司概况
    • 产品
    • 最新动态
  • Toyobo Co., Ltd.
    • 公司概况
    • 产品
    • 最新动态
  • Samsung BioLogics
    • 公司概况
    • 产品
    • 最新动态
  • Thermo Fisher Scientific, Inc.
    • 公司概况
    • 产品
    • 最新动态
  • Binex Co., Ltd.
    • 公司概况
    • 产品
    • 最新动态
  • WuXi Biologics
    • 公司概况
    • 产品
    • 最新动态
  • AbbVie, Inc.
    • 公司概况
    • 产品
    • 最新动态

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR11214545

The global demand for Biopharmaceuticals Contract Manufacturing Market is presumed to reach the market size of nearly USD 33.92 Billion by 2032 from USD 19.74 Billion in 2023 with a CAGR of 6.2% under the study period 2024 - 2032.

Biopharmaceuticals contract manufacturing involves outsourcing the production of biopharmaceutical products to specialized contract manufacturers. These products include biologics such as monoclonal antibodies, vaccines, and recombinant proteins, which require complex manufacturing processes and stringent quality control. Contract manufacturing organizations (CMOs) provide services, including cell line development, process development, and large-scale production. This model allows biopharmaceutical companies to leverage the expertise and capabilities of CMOs, reducing the need for in-house manufacturing facilities and associated capital expenditures. Companies can focus on research and development by outsourcing production while benefiting from the CMOs' advanced technologies and regulatory compliance expertise.

Market Dynamics

The biopharmaceuticals contract manufacturing market is experiencing robust growth attributed to the rising demand for biologics & advanced therapeutics. Biopharmaceutical companies outsource manufacturing to specialized contract manufacturers to scale production capabilities and meet the growing market demand for complex biologic drugs, such as monoclonal antibodies and gene therapies. Biopharmaceutical production's high cost and complexity drive the need for contract manufacturing services. Contract manufacturers offer expertise in handling sophisticated production processes and maintaining stringent quality standards, which can be cost-prohibitive for individual companies to manage in-house. Biopharmaceutical firms can reduce capital investments and operational costs while accessing state-of-the-art manufacturing technologies by outsourcing.

Technological advancements in bio-manufacturing are creating new opportunities within the market. Innovations such as single-use technologies and continuous manufacturing processes enhance production efficiency and flexibility. These advancements enable faster turnaround times and reduced risk of contamination, making contract manufacturing an attractive option for biopharmaceutical companies. The emerging trend of personalized medicine is also contributing to the growth of the biopharmaceuticals contract manufacturing market. The need for small-batch, high-quality production of personalized therapeutics is well-suited to contract manufacturers' capabilities. Additionally, the expansion of the biotechnology sector and increasing investments in biopharmaceutical R&D are driving demand for contract manufacturing services. However, regulatory complexities and the risk of intellectual property theft may hinder biopharmaceuticals contract manufacturing market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of biopharmaceuticals contract manufacturing. The growth and trends of biopharmaceuticals contract manufacturing industry provide a holistic approach to this study.

Market Segmentation

This section of the biopharmaceuticals contract manufacturing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Source

  • Mammalian
  • Non-mammalian

By Service

  • Process Development (Downstream, Upstream)
  • Fill & Finish Operations
  • Analytical & QC Studies
  • Packaging

By Product

  • Biologics (Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi, & Molecular Therapy, Others)
  • Biosimilars
  • Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Biopharmaceuticals Contract Manufacturing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the biopharmaceuticals contract manufacturing market include Boehringer Ingelheim GmbH, Lonza, Inno Biologics Sdn Bhd, Rentschler Biotechnologie GmbH, JRS Pharma, AGC Biologics, ProBioGen, Fujifilm Diosynth Biotechnologies U.S.A., Inc., Toyobo Co., Ltd., Samsung BioLogics, Thermo Fisher Scientific, Inc., Binex Co., Ltd., WuXi Biologics, AbbVie, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . BIOPHARMACEUTICALS CONTRACT MANUFACTURING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Source
    • 3.7.2 By Service
    • 3.7.3 By Product
    • 3.7.4 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET ANALYSIS BY SOURCE

  • 6.1 Overview by Source
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Source
  • 6.4 Mammalian Market by Regions
  • 6.5 Non-mammalian Market by Regions

7 . GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET ANALYSIS BY SERVICE

  • 7.1 Overview by Service
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Service
  • 7.4 Process Development Market by Regions
  • 7.5 Fill & Finish Operations Market by Regions
  • 7.6 Analytical & QC Studies Market by Regions
  • 7.7 Packaging Market by Regions

8 . GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET ANALYSIS BY PRODUCT

  • 8.1 Overview by Product
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Product
  • 8.4 Biologics Market by Regions
  • 8.5 Biosimilars Market by Regions

9 . GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America
    • 9.3.1. Overview, Historic and Forecast Data
    • 9.3.2. North America By Segment
    • 9.3.3. North America By Country
    • 9.3.4. United State
    • 9.3.5. Canada
    • 9.3.6. Mexico
  • 9.4. Europe
    • 9.4.1. Overview, Historic and Forecast Data
    • 9.4.2. Europe by Segment
    • 9.4.3. Europe by Country
    • 9.4.4. United Kingdom
    • 9.4.5. France
    • 9.4.6. Germany
    • 9.4.7. Italy
    • 9.4.8. Russia
    • 9.4.9. Rest Of Europe
  • 9.5. Asia Pacific
    • 9.5.1. Overview, Historic and Forecast Data
    • 9.5.2. Asia Pacific by Segment
    • 9.5.3. Asia Pacific by Country
    • 9.5.4. China
    • 9.5.5. India
    • 9.5.6. Japan
    • 9.5.7. South Korea
    • 9.5.8. Australia
    • 9.5.9. Rest Of Asia Pacific
  • 9.6. Latin America
    • 9.6.1. Overview, Historic and Forecast Data
    • 9.6.2. Latin America by Segment
    • 9.6.3. Latin America by Country
    • 9.6.4. Brazil
    • 9.6.5. Argentina
    • 9.6.6. Peru
    • 9.6.7. Chile
    • 9.6.8. Rest of Latin America
  • 9.7. Middle East & Africa
    • 9.7.1. Overview, Historic and Forecast Data
    • 9.7.2. Middle East & Africa by Segment
    • 9.7.3. Middle East & Africa by Country
    • 9.7.4. Saudi Arabia
    • 9.7.5. UAE
    • 9.7.6. Israel
    • 9.7.7. South Africa
    • 9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE BIOPHARMACEUTICALS CONTRACT MANUFACTURING COMPANIES

  • 10.1. Biopharmaceuticals Contract Manufacturing Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF BIOPHARMACEUTICALS CONTRACT MANUFACTURING INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Boehringer Ingelheim GmbH
    • 11.3.1. Company Overview
    • 11.3.2. Financials
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Lonza
    • 11.4.1. Company Overview
    • 11.4.2. Financials
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Inno Biologics Sdn Bhd
    • 11.5.1. Company Overview
    • 11.5.2. Financials
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Rentschler Biotechnologie GmbH
    • 11.6.1. Company Overview
    • 11.6.2. Financials
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. JRS Pharma
    • 11.7.1. Company Overview
    • 11.7.2. Financials
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. AGC Biologics
    • 11.8.1. Company Overview
    • 11.8.2. Financials
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. ProBioGen
    • 11.9.1. Company Overview
    • 11.9.2. Financials
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Fujifilm Diosynth Biotechnologies U.S.A., Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financials
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Toyobo Co., Ltd.
    • 11.11.1. Company Overview
    • 11.11.2. Financials
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Samsung BioLogics
    • 11.12.1. Company Overview
    • 11.12.2. Financials
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Thermo Fisher Scientific, Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Financials
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Binex Co., Ltd.
    • 11.14.1. Company Overview
    • 11.14.2. Financials
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. WuXi Biologics
    • 11.15.1. Company Overview
    • 11.15.2. Financials
    • 11.15.3. Products
    • 11.15.4. Recent Developments
  • 11.16. AbbVie, Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Financials
    • 11.16.3. Products
    • 11.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Source (USD MN)
  • Mammalian Market by Geography (USD MN)
  • Non-mammalian Market by Geography (USD MN)
  • Analysis Market by Service (USD MN)
  • Process Development Market by Geography (USD MN)
  • Fill & Finish Operations Market by Geography (USD MN)
  • Analytical & QC Studies Market by Geography (USD MN)
  • Packaging Market by Geography (USD MN)
  • Analysis by Product (USD MN)
  • Biologics Market by Geography (USD MN)
  • Biosimilars Market by Geography (USD MN)
  • Global Biopharmaceuticals Contract Manufacturing Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Biopharmaceuticals Contract Manufacturing Report
  • Market Research Process
  • Market Research Methodology
  • Global Biopharmaceuticals Contract Manufacturing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Source
  • Market Attractiveness Analysis by Service
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Source (USD MN)
  • Mammalian Market by Geography (USD MN)
  • Non-mammalian Market by Geography (USD MN)
  • Global Market Analysis by Service (USD MN)
  • Process Development Market by Geography (USD MN)
  • Fill & Finish Operations Market by Geography (USD MN)
  • Analytical & QC Studies Market by Geography (USD MN)
  • Packaging Market by Geography (USD MN)
  • Global Market Analysis by Product (USD MN)
  • Biologics Market by Geography (USD MN)
  • Biosimilars Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.